Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the target of a significant drop in short interest in December. As of December 15th, there was short interest totalling 400 shares, a drop of 75.0% from the November 30th total of 1,600 shares. Based on an average daily trading volume, of 280,200 shares, the days-to-cover ratio is currently 0.0 days.
Analyst Ratings Changes
Separately, The Goldman Sachs Group initiated coverage on Merck KGaA in a research note on Thursday, September 19th. They issued a “buy” rating for the company.
Read Our Latest Stock Report on MKKGY
Merck KGaA Trading Up 1.0 %
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
- Five stocks we like better than Merck KGaA
- What is the Hang Seng index?
- Top 3 Investment Themes to Watch for in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Consumer Staples Stocks, Explained
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.